McMinn Rachel

CIK 00016063022 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001606302

Recent Transactions

28 trades

Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2026-02-20+155,100→ 155,100 total
Award
Neurogene Inc.$NGNE
Common Stock
2026-02-20+25,900→ 1,347,659 total
Award
Neurogene Inc.$NGNE
Common Stock
2025-03-26+23,900→ 1,274,259 total
Award
Neurogene Inc.$NGNE
Employee Stock Option (Right to buy)
2025-03-26+143,500→ 143,500 total
Purchase
Neurogene Inc.$NGNE
Common Stock
2024-11-22$20.40/sh+47,500→ 1,297,859 total
Award
Neurogene Inc.$NGNE
Employee Stock Option (Right to buy)
2024-03-13+93,282→ 93,282 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2017-10-02$58.89/sh−283→ 16,875 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2017-07-31$123.12/sh−130→ 17,158 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2017-07-03$121.78/sh−257→ 17,288 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2017-05-01$113.12/sh−114→ 17,545 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2017-04-03$115.00/sh−257→ 17,659 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2017-02-01+8,300→ 8,300 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2017-02-01+5,000→ 17,916 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2017-01-03$103.92/sh−816→ 12,916 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2016-10-31$123.82/sh−129→ 13,732 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2016-08-01$176.56/sh−125→ 13,861 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2016-07-05$145.11/sh−106→ 13,986 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2016-05-02$147.49/sh−130→ 14,087 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2016-04-04$130.76/sh−104→ 14,217 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2016-02-10+6,700→ 14,321 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2016-02-10+8,800→ 8,800 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2016-02-01$103.56/sh−128→ 7,621 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2016-01-04$145.90/sh−469→ 7,749 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2015-11-02$160.24/sh−125→ 8,218 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2015-10-01+4,050→ 8,343 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2015-10-01+10,600→ 10,600 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2015-07-31$262.09/sh−127→ 4,293 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2015-05-01$255.12/sh−503→ 4,420 total

Companies

Recent Filings

Address

C/O NEUROGENE INC. 535 W 24TH STREET, 5TH FLOOR

NEW YORK, NY, 10011

View on SEC.gov